TMS approved as adjunct treatment for OCD by FDA

The US food and drug administration has approved transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for patients with obsessive compulsive disorder.

NeuroStar pioneered the TMS category as the first system FDA cleared for Major Depressive Disorder (MDD). NeuroStar is now leveraging the system's versatile coil design, which allows providers to treat both MDD and OCD without the need for additional hardware upgrades or purchases. NeuroStar's proprietary cloud-based software, TrakStar, can remotely activate the new treatment protocol for providers once they are trained.

Practice Development Managers and Clinical Training Managers will be available to deliver training to NeuroStar practices in the third quarter. This new indication will significantly add to NeuroStar's extensive Outcomes Registry, which is the largest outcomes registry in the world for depression.

"Despite the severe functional impairment that OCD can cause, unfortunately, only one third of individuals with OCD seek treatment," said Scott West, MD, Chief Medical Officer at Nashville NeuroCare Therapy. "NeuroStar receiving FDA clearance for OCD is important for my practice because more patients will have access to an effective and safe TMS treatment for both MDD and OCD without needing to buy any new equipment."

This is evidence of our commitment and strategic initiative to accelerate new clinical indications for NeuroStar," stated Cory Anderson, VP of R&D and Clinical. "This new indication means that NeuroStar can help even more people suffering from mental health disorders that can be debilitating in their daily lives."

Despite the severe functional impairment that OCD can cause, unfortunately, only one-third of individuals with OCD seek treatment," Scott West, MD, chief medical officer at Nashville NeuroCare Therapy, said in the release. "NeuroStar receiving FDA clearance for OCD is important for my practice because more patients will have access to an effective and safe TMS treatment for both MDD and OCD without needing to buy any new equipment."